MITRAClip GENeration 5 Mitral Valve Transcatheter Edge-to-Edge Repair Registry

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital of Cologne

About this trial

The MITRAGEN5 Registry is an international, multicenter, observational registry that collects data on patients with mitral regurgitation who are treated with the fifth-generation MitraClip (G5) device. The MitraClip is a small device used to repair the mitral valve of the heart without open-heart surgery, a procedure called mitral valve transcatheter edge-to-edge repair (M-TEER). This registry aims to evaluate how safe and effective the MitraClip G5 is in everyday clinical practice across multiple hospitals worldwide. All procedures, tests, and follow-up visits are part of routine clinical care. No additional study-specific procedures are performed. Data are collected in anonymized form from participating centers.

Eligibility criteria

Qualifiers

Age 18 years or older at the time of M-TEER

Treatment using the MitraClip G5 system

Disqualifiers

None

Trial design

Treatments tested in this trial

  • MitraClip G5

Treatment groups

1,000 Participants
are divided into 1 treatment group

Locations

This trial has no locations

Sponsors and collaborators

University Hospital of Cologne

Lead sponsor

Montefiore Medical Center

Collaborator

Cardiovascular Research Foundation, New York

Collaborator